Zhou, J., Wu, X., Du, Y., Xiao, J., Kang, X., Chen, J., Wang, X., Tai, Y., Bian, L., Zhang, S., Pang, Z., Li, Y., Jiang, Z., Xu, X., Wang, T. (2026). Dalpiciclib plus chidamide in HR + /HER2−advanced breast cancer after CDK4/6 inhibitor failure: a phase Ib trial. Nature Communications. https://doi.org/10.1038/s41467-026-70650-6